Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

ClinicalTrials.gov ID: NCT02343458

Public ClinicalTrials.gov record NCT02343458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A chronic dosing (24 weeks) study to assess the efficacy and safety GFF MDI; PT003), FF MDI; PT005, and GP MDI; PT001) in subjects with moderate to very severe COPD, compared with placebo.

Study identification

NCT ID
NCT02343458
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pearl Therapeutics, Inc.
Industry
Enrollment
1,756 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 30, 2015 (Actual)
Primary completion
Aug 31, 2017 (Actual)
Completion
Aug 31, 2017 (Actual)
Last update posted
Feb 20, 2019

2015 – 2017

United States locations

U.S. sites
44
U.S. states
15
U.S. cities
40
Facility City State ZIP Site status
Research Site Andalusia Alabama 36420 —
Research Site Birmingham Alabama 35209 —
Research Site Foley Alabama 36535 —
Research Site Jasper Alabama 35501 —
Research Site Anaheim California 92801 —
Research Site Boulder Colorado 80301 —
Research Site Clearwater Florida 33756 —
Research Site Clearwater Florida 33765 —
Research Site Kissimmee Florida 34744 —
Research Site Miami Florida 33175 —
Research Site Miami Florida 33186 —
Research Site Panama City Florida 32405 —
Research Site Pensacola Florida 32503 —
Research Site Tamarac Florida 33321 —
Research Site Tampa Florida 33603 —
Research Site Winter Park Florida 32789-4681 —
Research Site Atlanta Georgia 30331 —
Research Site Blue Ridge Georgia 30513 —
Research Site North Dartmouth Massachusetts 02747 —
Research Site Edina Minnesota 55435 —
Research Site Fridley Minnesota 55432 —
Research Site Minneapolis Minnesota 55407 —
Research Site Woodbury Minnesota 55125 —
Research Site Saint Charles Missouri 63301 —
Research Site St Louis Missouri 63141 —
Research Site Gastonia North Carolina 28054 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Cincinnati Ohio 45242 —
Research Site Columbus Ohio 43215 —
Research Site Columbus Ohio 43231 —
Research Site Dayton Ohio 45419 —
Research Site Dayton Ohio 45459 —
Research Site Dublin Ohio 43016 —
Research Site Oklahoma City Oklahoma 73103 —
Research Site Medford Oregon 97504 —
Research Site Easley South Carolina 29640 —
Research Site Gaffney South Carolina 29341 —
Research Site Greenville South Carolina 29615 —
Research Site Rock Hill South Carolina 29732 —
Research Site Seneca South Carolina 29678 —
Research Site Spartanburg South Carolina 29303 —
Research Site Union South Carolina 29379 —
Research Site Johnson City Tennessee 37601 —
Research Site Abingdon Virginia 24210 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 122 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02343458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02343458 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →